Mantle Cell Lymphoma | Topics

 
Maintenance With Rituximab for MCL Prolongs Time to Next Treatment
June 15, 2021

Real-world evidence evaluating the efficacy of rituximab maintenance following frontline BR or R-CHOP supports its use in mantle cell lymphoma.

High Rate of Response Noted in MCL and CLL With Cirmtuzumab Plus Ibrutinib
June 06, 2021

Most patients with either mantle cell lymphoma or chronic lymphocytic leukemia who were treated in a phase 1/2 trial had a response to therapy with the combination of cirmtuzumab plus ibrutinib.

Study Suggests Unsatisfactory Survival in Elderly Patients After Attenuated Therapy for Mantle Cell Lymphoma
June 01, 2021

A retrospective analysis aims to define treatment outcomes in patients with mantle cell lymphoma who are elderly or unfit for standard therapy.